Guidelines for the pharmacological treatment of peripheral neuropathic pain

LAUR Repository

Show simple item record

dc.contributor.author Riachi, N.
dc.contributor.author Bohlega, S.
dc.contributor.author Alsaadi, T.
dc.contributor.author Amir, A.
dc.contributor.author Hosny, H.
dc.contributor.author Karawagh, A.M.
dc.contributor.author Moulin, D.
dc.contributor.author Salti, A.
dc.contributor.author Shelbaya, S.
dc.date.accessioned 2019-04-30T12:53:14Z
dc.date.available 2019-04-30T12:53:14Z
dc.date.copyright 2010 en_US
dc.identifier.issn 1473-2300 en_US
dc.identifier.uri http://hdl.handle.net/10725/10511
dc.description.abstract Neuropathic pain (NeP) has been the focus of extensive basic and clinical research over the past 20 years. This has led to an increased understanding of underlying pathophysiological mechanisms and the development of new therapeutic agents, as well as a clearer definition of the role of established medications. To date there are no published treatment guidelines for NeP in the Middle East. A multidisciplinary panel of Middle East and international experts met to review critically and reach a consensus on how best to apply evidence-based guidelines for the treatment of NeP (mainly peripheral NeP) in the Middle East. The expert panel recommended pregabalin, gabapentin and secondary amine tricyclic antidepressants (nortriptyline and desipramine) as first-line treatments for peripheral NeP. Serotonin-norepinephrine reuptake inhibitor antidepressants, tramadol and controlled-release opioid analgesics were recommended as second-line treatments. There is a need to increase diagnostic awareness of NeP, use validated screening questionnaires and undertake more treatment research in the Middle East region. en_US
dc.language.iso en en_US
dc.title Guidelines for the pharmacological treatment of peripheral neuropathic pain en_US
dc.type Article en_US
dc.description.version Published en_US
dc.title.subtitle expert panel recommendations for the middle east region en_US
dc.author.school SOM en_US
dc.author.idnumber 200902731 en_US
dc.author.department N/A en_US
dc.description.embargo N/A en_US
dc.relation.journal Journal of International Medical Research en_US
dc.journal.volume 38 en_US
dc.journal.issue 2 en_US
dc.article.pages 295-317 en_US
dc.keywords Antidepressants en_US
dc.keywords Anticonvulsants en_US
dc.keywords Pregabalin en_US
dc.keywords Gabapentin en_US
dc.keywords Nortriptyline en_US
dc.keywords Desipramine en_US
dc.keywords Neuropathic pain en_US
dc.keywords Middle East en_US
dc.keywords Consensus en_US
dc.keywords Guidlines en_US
dc.keywords Guidelines en_US
dc.identifier.doi https://doi.org/10.1177/147323001003800201 en_US
dc.identifier.ctation Bohlega, S., Alsaadi, T., Amir, A., Hosny, H., Karawagh, A. M., Moulin, D., ... & Shelbaya, S. (2010). Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region. Journal of International Medical Research, 38(2), 295-317. en_US
dc.author.email naji.riachi@lau.edu.lb en_US
dc.identifier.tou http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php en_US
dc.identifier.url https://journals.sagepub.com/doi/abs/10.1177/147323001003800201 en_US
dc.author.affiliation Lebanese American University en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search LAUR

Advanced Search


My Account